Medicine and Dentistry
Chronic Hepatitis B
100%
Hepatocellular Carcinoma
98%
Population
95%
Cohort Analysis
87%
Collagenous Colitis
83%
Hepatitis A
83%
Hepatitis C Virus
83%
Ascites
83%
Liver Cirrhosis
81%
Hepatitis B Virus
79%
Chronic Hepatitis C
69%
Antivirus Agent
69%
Spontaneous Bacterial Peritonitis
62%
Hepatorenal Syndrome
55%
Hyponatremia
55%
Decompensated Liver Cirrhosis
46%
Diseases
43%
Ischemic Heart Disease
41%
Polyacrylamide Gel Electrophoresis
41%
Placebo
41%
Grazoprevir
41%
Ribavirin
41%
Nitric Oxide
41%
Symptom
41%
Mortality Rate
41%
Diagnosis
34%
Hepatology
34%
Pathophysiology
34%
Acute Hepatitis A
27%
All Cause Mortality
24%
Prevalence
23%
Maintenance Therapy
20%
Nonstructural Protein 5A Inhibitor
17%
Cumulative Incidence
16%
Phenmetrazine
13%
Hepatitis Virus
13%
Drug Withdrawal
13%
Virus Transmission
13%
Liver Biopsy
13%
Transaminase
13%
Fibrosis
13%
Autoantigen
13%
Immunoregulation
13%
Personal Identification
13%
Hepatitis C
11%
Arm
11%
Drug Therapy
10%
Endocrine Disease
10%
Liver Disease
10%
Neoplasm
10%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Hepatitis B
100%
Liver Cell Carcinoma
98%
Cohort Study
87%
Hepatitis A
83%
Hepatitis B Virus
79%
Chronic Hepatitis C
62%
Antivirus Agent
62%
Prevalence
52%
Decompensated Liver Cirrhosis
46%
Hepatitis C Virus Genotype 3
41%
Uprifosbuvir
41%
Grazoprevir
41%
Ruzasvir
41%
Normal Human
41%
Polyacrylamide Gel Electrophoresis
41%
Mortality Rate
41%
Ischemic Heart Disease
41%
Nitric Oxide
41%
Autoimmune Hepatitis
41%
Elimination
41%
Hepatitis C Virus
41%
Respiratory Tract Inflammation
41%
Acute Hepatitis A
27%
Comorbidity
26%
Population Study
25%
All Cause Mortality
24%
Hepatitis C Virus Genotype 1
20%
Chronic Lung Disease
20%
Lung Infection
20%
Biological Marker
20%
Nonstructural Protein 5A Inhibitor
17%
Phenmetrazine
13%
Autoantigen
13%
Aminotransferase
13%
Genetic Predisposition
13%
Liver Cirrhosis
12%
Virus Hepatitis
10%
Endocrine Disease
10%
Interleukin 28B
10%
Neoplasm
10%
Virus Transmission
10%
Urogenital Tract Disease
10%
Liver Disease
10%
Disease
8%
Hepatitis B
5%
Mortality
5%
Keyphrases
Ascites
83%
Spontaneous Bacterial Peritonitis
62%
Hepatorenal Syndrome
55%
Apoptotic Genes
41%
Budesonide
41%
Collagenous Colitis
41%
Denmark
41%
Primary Liver Cancer
41%
Hyponatremia
41%
Cirrhosis
41%
Cerebral Reorganization
41%
Hepatitis A
41%
Patient Survival
41%
Sofosbuvir
41%
Ruzasvir
41%
Diagnostic Aspects
34%
Evidence-based Guidelines
34%
Hepatology
34%
Parts per Billion
32%
Acute Hepatitis A
27%
Trigger Factor
27%
Direct-acting Antivirals
27%
SVR12
23%
Disease Course
20%
Pathophysiology
20%
Danish Society
20%
National Guidelines
20%
Clinical Remission
18%
NS5A Inhibitor
17%
Interferon Treatment
13%
Diagnostic Treatment
13%
Population-based Setting
13%
Drug Withdrawal
13%
Diagnostic Procedures
13%
Histological Changes
13%
Serious Diseases
13%
Pale Stool
13%
Improved Survival
13%
High Mortality
13%
Micro-elimination
13%
Virus Incidence
13%
All-oral Regimen
11%
Stool Frequency
10%
Stool Weight
10%
Genitourinary Syndrome
10%
PAGE-B Score
10%
Eosinophilic Airway Inflammation
9%
Somatosensory Evoked Potentials
8%
Auditory Reaction Time
8%
Cerebral Function
8%